Related by context. Frequent words. (Click for all words.) 72 NMP# R 61 Taiho Pharmaceutical 60 Septin 9 59 Uracyst ® 59 StromaCel Inc. 59 topical non steroidal 59 MassARRAY R 58 Onalta 58 Flagship Product 58 Elan Pharma 58 immunodiagnostic 58 Patent Covering 58 Receives Orphan Drug Designation 58 BioSante licensees 58 Affymetrix GeneChip ® 58 BioCheck 57 FDA Clears 57 Milestone Payment 57 Uracyst 57 Announces FDA Clearance 57 Drug Candidate 57 Uracyst R 57 Ceragenix 57 PentaStaph 56 Distribution Agreements 56 Diagnostic Tests 56 Announces Immediate Availability 56 NMP# 56 Intellectual Property Portfolio 56 Provides Shareholder 56 Galenea 56 Initiates Phase II 56 Biosite Incorporated 56 Epitomics 56 Commercialization Agreement 56 Nippon Kayaku 56 Aegis Therapeutics 56 PreGen Plus 56 Epidermal Growth Factor Receptor 55 InnerCool Therapies 55 Source MDx 55 CardioVascular BioTherapeutics Inc. 55 Develop Novel 55 Receives Patent 55 Exclusive License 55 Vitro Diagnostic 55 RNAi Therapeutics 55 FDA Accepts 55 nucleic acid purification 55 Phase III Clinical Trial 55 Budesonide 55 Announces Initiation 55 Combidex 54 reagent kits 54 Registered Trademark 54 Ibis T# 54 Regains Compliance 54 GeneChip R 54 Seamless Integration 54 Vascular Closure Device 54 Signs Licensing 54 Signs Licensing Agreement 54 FACTIVE R gemifloxacin 54 Lubiprostone 54 Acquires Exclusive 54 BioGlue R 54 Waytronx Inc. 54 Argatroban 54 Inks Distribution 54 optical biosensors 54 Receives FDA Clearance 54 SonoPrep 54 ZYFLO R 53 NicAlert TM 53 Helsinn Healthcare SA 53 Presents Positive 53 Multi Platform 53 Option Grants 53 SemEquip 53 Awarded Patent 53 theranostic 53 Valera Pharmaceuticals 53 Generic Version 53 Testim R 53 Thiarabine 53 include DSM Biologics 53 HepeX B 53 Taiho Pharmaceutical Co. 53 Completes Initial 53 Completes Enrollment 53 XEROX CORPORATION 53 Intermap Technologies Corporation 53 Announces Cancellation 53 Completes Tender Offer 53 Watson LIMS 53 Clearant Inc. 53 Delivers Next Generation 53 Successfully Completed 53 Loramyc R 52 Aradigm Corporation 52 Fast Track Status